THIS PROJECT PROPOSAL AIMS AT THE INDUSTRIALISATION AND MARKETING OF CUSTOMISED NUTRACEUTICALS FOR THE PREVENTION AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD). AMD Ê THE MOST IMPORTANT CAUSE OF IRREVERSIBLE VISUAL LOSS IN THE WEST AND Ê CHARACTERISED BY THE DEPOSITION ON THE RETINA OF CELLULAR DEBRIS ARRANGED IN CLUSTERS CALLED ‘DRUSEN’, CLINICALLY CLASSIFIED IN THE VARIOUS TYPES OF ATROPHY OR NOVASCOLARI, WHICH HAVE A DIFFERENT PROGNOSIS. ALTHOUGH THE MAJORITY OF THOSE AFFECTED BY AMD DO NOT BECOME TOTALLY BLIND, LOSS OF THE VISUAL FUNCTION IS SEVERELY DEBILITATING, LEADING TO FUNCTIONAL FAILURES. THE RISK FACTORS FOR AMD INCLUDE ENVIRONMENTAL FACTORS SUCH AS LIFESTYLE (WITH SMOKING AND NEGATIVELY BEING NEGATIVELY AFFECTED), AND LEVERAGING, THESE FACTORS MAKE UP 40 % OF AMD’S RISK. FURTHERMORE, THEY HAVE A STRONG GENE BASE, WITH A PROMINENT ROLE PLAYED BY G